Latest Schedule 13G passive stakes

Linden Capital L.P. and affiliated entities have filed an amendment to their Schedule 13G, confirming zero beneficial ownership of Enhanced Group Inc. Class A Common Stock as of June 30, 2026.

Linden Capital L.P. and associated entities have filed an amendment to their Schedule 13G concerning Paloma Acquisition Corp I, detailing beneficial ownership as of June 30, 2026.

Earnest Partners, LLC has reported a beneficial ownership of 2,890,502 shares, representing 8.8% of the outstanding common stock of Papa John's International Inc. as of June 30, 2026.

StemPoint Capital LP, along with affiliated entities, has reported beneficial ownership of 628,866 shares, representing 9.5% of Xilio Therapeutics' common stock, primarily through warrants.

Parvus Asset Management Jersey Ltd and Edoardo Mercadante report a beneficial ownership of 15,191,321 ordinary shares in Flutter Entertainment plc, representing 8.8% of the class.

StemPoint Capital LP, along with affiliated entities, has reported beneficial ownership of 5.0% of Surrozen, Inc.'s common stock, primarily through warrant holdings.

Linden Capital L.P. and associated entities have filed an amendment to their Schedule 13G, reporting beneficial ownership of 750,000 ordinary shares in Future Money Acquisition Corporation as of June 30, 2026.

StemPoint Capital LP, StemPoint Capital Management GP LLC, and Michelle Ross have jointly filed an amendment to their Schedule 13G, reporting 0 shares beneficially owned in Faeth Therapeutics, Inc.

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amendment to their Schedule 13G, reporting 0.0% beneficial ownership of Four Leaf Acquisition Corporation's Class A common stock as of June 30, 2026.

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amendment to their Schedule 13G, reporting 0.0% beneficial ownership of Four Leaf Acquisition Corporation's Class A common stock as of June 30, 2026.

Centurion Acquisition Corp. has filed an amendment to its Schedule 13G, detailing beneficial ownership changes as of June 30, 2026.

Earnest Partners LLC has disclosed a beneficial ownership of 3,099,996 shares, representing 8.1% of the outstanding common stock of Insperity, Inc.

Several First Trust entities have jointly filed a Schedule 13G/A, reporting their beneficial ownership of Lionheart Holdings' Class A Ordinary Shares.

An investment group, including FF Hybrid, LP, Flat Footed LLC, and Marc Andersen, has increased its beneficial ownership of Diversified Healthcare Trust to 9.7%, holding 23,487,002 shares.

Bellevue Group AG and its subsidiary Bellevue Asset Management AG have reported beneficial ownership of 5.0% of Jade Biosciences, Inc. common stock.

Linden Capital L.P. and associated entities have filed an amendment to their Schedule 13G, updating beneficial ownership details for Safeguard Acquisition Corp. as of June 30, 2026.

Goldman Sachs Asset Management, L.P. has filed a Schedule 13G, reporting beneficial ownership of 5.1% of Knowles Corporation's common stock as of June 30, 2026.

Several First Trust entities have jointly filed an amended Schedule 13G, reporting their beneficial ownership of Drugs Made In America Acquisition Corp. Class A Ordinary Shares.

Evolution Global Acquisition Corp has filed an amendment to its Schedule 13G, detailing beneficial ownership changes as of June 30, 2026.

Ameriprise Financial, Inc. and its subsidiaries report significant beneficial ownership of Adeia Inc. common stock as of June 30, 2026.

Ameriprise Financial, Inc. and its subsidiaries report significant beneficial ownership of Adeia Inc. common stock as of June 30, 2026.

Linden Capital L.P. and associated entities have filed an amendment to their Schedule 13G, reporting beneficial ownership of Translational Development Acquisition Corp. Class A Ordinary Shares.

Goldman Sachs Asset Management, L.P. has filed an amended Schedule 13G, disclosing its beneficial ownership of Kirby Corporation's common stock.

Aquamarine Financial (Cayman) Ltd has filed a Schedule 13G, reporting beneficial ownership of 2,512,175 shares, representing 6.04% of Oramed Pharmaceuticals Inc.'s common stock.

First Trust Capital Management L.P. and its affiliates have reported a 2.51% beneficial ownership stake in Melar Acquisition Corp. I, as of June 30, 2026.

GMT Capital Corp. and Thomas E. Claugus have filed a Schedule 13G, reporting beneficial ownership of 545,200 shares of Cracker Barrel Old Country Store, Inc. common stock, representing 2.44% of the class.

Eventide Asset Management, LLC, along with individuals Finny Kuruvilla and Robin C. John, have reported beneficial ownership of 11,812,241 shares, representing 6.3% of Ovid Therapeutics Inc.'s common stock as of June 30, 2026.

GMT Capital Corp. and Thomas E. Claugus have filed an amendment to their Schedule 13G, reporting a beneficial ownership of 4.60% in Hudbay Minerals Inc. as of June 30, 2026.

Investment firms Westchester Capital Management, Westchester Capital Partners, and Virtus Investment Advisers have jointly reported beneficial ownership exceeding 5% of White Pearl Acquisition Corp.'s Class A ordinary shares.

Eventide Asset Management, LLC, along with Finny Kuruvilla and Robin C. John, has reported beneficial ownership of 5.6% of Immix Biopharma, Inc.'s common stock as of June 30, 2026.